ISRCTN79914298
Completed
Phase 4
Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care (ARTIC PC)
niversity of Southampton (UK)0 sites438 target enrollmentAugust 21, 2015
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- ower Respiratory Tract Infection in children aged 6 months - 12 years
- Sponsor
- niversity of Southampton (UK)
- Enrollment
- 438
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34562391/ (added 27/09/2021) 2023 Results article in https://doi.org/10.3310/dgbv3199 (added 13/07/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children between 6 months and 12 years old presenting with an acute lower respiratory infection (LRTI), defined as an acute cough as the predominant symptom, judged by the GP to be infective in origin, lasting \<21 days, and with other symptoms or signs localising to the lower tract (shortness of breath, sputum, pain)
- •Added 26/07/2016:
- •Individuals who are allergic to penicillin, who cannot be randomised (e.g. with known immune deficiency, or where a complication such as pneumonia is suspected on clinical grounds), or are unwilling to be randomised, are still eligible for the observational study where the same outcomes will be measured.
Exclusion Criteria
- •1\. The cough is judged by the clinician to have a non\-infectious aetiology (e.g., hayfever or non\-infective exacerbation of asthma) or almost certain viral aetiology (croup, where antibiotics are not commonly prescribed)
- •2\. Immune\-compromised
- •3\. Antibiotic use in previous 30 days
- •4\. For the trial, suspected pneumonia based on clinical examination or being very severely ill as judged by the GP is an exclusion (but such children can still enter the observational study which will allow for an assessment of trial participants’ external validity)
- •5\. Only one child from each household will be recruited
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Antibiotics for chest infections in children consulting with the GPRespiratory tract infections in children aged between 6 months and 12 yearsMedDRA version: 20.1Level: LLTClassification code 10066740Term: Acute respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10024968Term: Lower respiratory tract infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2015-002455-97-GBniversity of Southampton938
Completed
Not Applicable
Microbiome and lower respiratory tract infections in childrebronchitis or pneumoniaLower respiratory tract infections10019815NL-OMON44725Spaarne Ziekenhuis975
Recruiting
Not Applicable
MOL onderzoek - Microbioom en Onderste LuchtweginfectiesHealthy children, Microbiome, Lower respitory tract infection, Computer-tailoringNL-OMON23510innaeus Institute975
Active, not recruiting
Phase 1
The ATHENIAN Study: A clinical trial investigating the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory virusesPatients with viral respiratory tract infection (influenza virus, parainfluenza virus, respiratory syncytial virus or human metapneumovirus)Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2021-004248-11-NOAkershus University Hospital400
Active, not recruiting
Phase 1
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory virusesViral respiratory tract infectionTherapeutic area: Diseases [C] - Virus Diseases [C02]CTIS2023-509286-20-00Akershus University Hospital400